Literature DB >> 9219000

Loss of heterozygosity on chromosome arm 16q in breast cancer metastases.

K Driouch1, F Dorion-Bonnet, M Briffod, M H Champéme, M Longy, R Lidereau.   

Abstract

One of the main genetic abnormalities associated with breast carcinogenesis is the loss of genetic material from chromosome arm 16q. Different groups have identified two regions (16q22.1 and 16q24-ter) that are frequently deleted in primary tumors, suggesting the presence of tumor suppressor genes in these regions. Little is known about the late stages of tumor progression in this respect, and we, therefore, analyzed biopsy specimens of breast cancer metastases for deletions in these critical regions of 16q. We examined fine needle cytopunctures from 24 metastases, each with lymphocyte DNA, for allelic imbalance on 16q by means of polymerase chain reaction (PCR) with 15 highly polymorphic markers. All the metastatic samples showed deletion of at least one informative locus on 16q. The loss of heterozygosity (LOH) pattern often indicated the loss of a complete long arm of chromosome 16 (13 cases); nevertheless, in the remaining 11 samples, partial LOH patterns were observed. A small region of overlap (SR02) in 16q22.1 was frequently involved, whereas another (SR01) in 16q24-ter was affected in only two cases. A third region of LOH in 16q22.2-q23.2 was found in 6/11 samples. These results suggest that at least three different regions are involved in allelic imbalance on chromosome arm 16q in breast cancer. Loss of material from the third region could be a major event in the genesis of metastases.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9219000     DOI: 10.1002/(sici)1098-2264(199707)19:3<185::aid-gcc8>3.0.co;2-u

Source DB:  PubMed          Journal:  Genes Chromosomes Cancer        ISSN: 1045-2257            Impact factor:   5.006


  16 in total

1.  WWOX mRNA expression profile in epithelial ovarian cancer supports the role of WWOX variant 1 as a tumour suppressor, although the role of variant 4 remains unclear.

Authors:  C Gourley; A J W Paige; K J Taylor; D Scott; N-J Francis; R Rush; C M Aldaz; J F Smyth; H Gabra
Journal:  Int J Oncol       Date:  2005-06       Impact factor: 5.650

2.  Multiplex loss of heterozygosity analysis by using single or very few cells.

Authors:  Xiangfeng Cui; Helen Feiner; Honghua Li
Journal:  J Mol Diagn       Date:  2002-08       Impact factor: 5.568

3.  Pooled analysis of loss of heterozygosity in breast cancer: a genome scan provides comparative evidence for multiple tumor suppressors and identifies novel candidate regions.

Authors:  Brian J Miller; Daolong Wang; Ralf Krahe; Fred A Wright
Journal:  Am J Hum Genet       Date:  2003-09-16       Impact factor: 11.025

4.  Common polymorphism in the phosphatase PHLPP2 results in reduced regulation of Akt and protein kinase C.

Authors:  John Brognard; Matthew Niederst; Gloria Reyes; Noel Warfel; Alexandra C Newton
Journal:  J Biol Chem       Date:  2009-03-26       Impact factor: 5.157

5.  Epithelial and fibroblast cell lines derived from a spontaneous mammary carcinoma in a MMTV/neu transgenic mouse.

Authors:  Michael J Campbell; Wendy S Wollish; Margaret Lobo; Laura J Esserman
Journal:  In Vitro Cell Dev Biol Anim       Date:  2002-06       Impact factor: 2.416

6.  Comparative epigenomics of human and mouse mammary tumors.

Authors:  Berna Demircan; Lisa M Dyer; Mallory Gerace; Edward K Lobenhofer; Keith D Robertson; Kevin D Brown
Journal:  Genes Chromosomes Cancer       Date:  2009-01       Impact factor: 5.006

Review 7.  Molecular Functions of WWOX Potentially Involved in Cancer Development.

Authors:  Karim Taouis; Keltouma Driouch; Rosette Lidereau; François Lallemand
Journal:  Cells       Date:  2021-04-29       Impact factor: 6.600

8.  WWOX expression in colorectal cancer--a real-time quantitative RT-PCR study.

Authors:  Maciej Jakub Żelazowski; Elżbieta Płuciennik; Grażyna Pasz-Walczak; Piotr Potemski; Radzisław Kordek; Andrzej Kazimierz Bednarek
Journal:  Tumour Biol       Date:  2011-02-25

9.  A critical evaluation of loss of heterozygosity detected in tumor tissues, blood serum and bone marrow plasma from patients with breast cancer.

Authors:  Heidi Schwarzenbach; Volkmar Müller; Cord Beeger; Miriam Gottberg; Nicole Stahmann; Klaus Pantel
Journal:  Breast Cancer Res       Date:  2007       Impact factor: 6.466

10.  CDH1 promoter hypermethylation and E-cadherin protein expression in infiltrating breast cancer.

Authors:  José Roberto F Caldeira; Erika C Prando; Francisco C Quevedo; Francisco A Moraes Neto; Cláudia A Rainho; Silvia R Rogatto
Journal:  BMC Cancer       Date:  2006-03-02       Impact factor: 4.430

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.